Cumberland Pharmaceuticals Inc

CPIXNASDAQUSD
5.47 USD
0.55 (11.18%)AT CLOSE (11:59 AM EDT)
5.24
0.23 (4.30%)
POST MARKET (AS OF 04:21 PM EDT)
Post Market
AS OF 04:21 PM EDT
5.24
0.23 (4.30%)
🟢Market: OPEN
Open?$4.79
High?$5.52
Low?$4.79
Prev. Close?$4.92
Volume?287.1K
Avg. Volume?1.9M
VWAP?$5.21
Rel. Volume?0.15x
Bid / Ask
Bid?$4.21 × 100
Ask?$6.30 × 100
Spread?$2.09
Midpoint?$5.26
Valuation & Ratios
Market Cap?73.7M
Shares Out?15.0M
Float?8.8M
Float %?58.1%
P/E Ratio?N/A
P/B Ratio?3.41
EPS?-$0.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Employees
93
Market Cap
73.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2009-08-11
Address
1600 WEST END AVENUE
NASHVILLE,, TN 37203
Phone: 615-255-0068
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.95Weak
Quick Ratio?0.79Weak
Cash Ratio?0.32Low
Debt/Equity?0.24Low
ValuationATTRACTIVELY VALUED
Score
80/100
P/E?
N/A
P/B?
3.41FAIR
P/S?
1.76CHEAP
P/FCF?
53.8PRICEY
EV/EBITDA?
-24.1CHEAP
EV/Sales?
1.62CHEAP
Returns & Efficiency
ROE?
-34.1%WEAK
ROA?
-10.4%WEAK
Cash Flow & Enterprise
FCF?$1.4M
Enterprise Value?$68.0M
Fundamentals ratios updated end of day